Volume 33, Issue 227 (12-2023)                   J Mazandaran Univ Med Sci 2023, 33(227): 118-125 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Amjadi O, Samadi F, Alizadeh-Navaei R, Valadan R, Zaboli E, Ahangar N, et al . Investigation of Mir-210 Expression in Breast Cancer Patients. J Mazandaran Univ Med Sci 2023; 33 (227) :118-125
URL: http://jmums.mazums.ac.ir/article-1-20231-en.html
Abstract:   (720 Views)
Background and purpose: Breast cancer is one of the most common cancers among women. Abnormal expression of microRNAs is associated with cancer. Therefore, this study aimed to evaluate the expression of miRNA-210 in the serum of breast cancer patients.
Materials and methods: The studied population included 49 breast cancer patients and 55 healthy individuals, and the samples were evaluated using Real Time PCR.
Results: The data analysis of this study revealed that the expression level of miR-210 in the blood of breast cancer patients is significantly higher compared to the blood of healthy people. Also, there is a negative correlation between the age of breast cancer patients and the expression of miR-210 (r=-0.309, P=0.031) and a significant positive correlation between the increase in the expression of mir-210 and the expression of the Ki-67 marker (r=0.412, P = 0.004).

 
Full-Text [PDF 912 kb]   (306 Downloads)    
Type of Study: Brief Report | Subject: Hematology and Oncology

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Mazandaran University of Medical Sciences

Designed & Developed by : Yektaweb